欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
3-Deazaneplanocin A_102052-95-9_产品详情
102052-95-9
  • 3-Deazaneplanocin A

  • names:

    3-Deazaneplanocin A

  • CAS号:

    102052-95-9

    MDL Number:
  • MF(分子式): C12H14N4O3 MW(分子量): 262.26
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
3-Deazaneplanocin A
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM003063-10mg 10mg 98.12% ¥ 8977.50 ¥ 8977.50 Backorder
- +
¥ 0.00
YZM003063-5mg 5mg 98.12% ¥ 5461.30 ¥ 5461.30 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 102052-95-9
Inchi
InchiKey
分子式 Formula C12H14N4O3
分子量 Molecular Weight 262.26
溶解度Solubility In Vivo:1.3-Deazaneplanocin A (DZNep) is prepared in PBS[5].
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
3-Deazaneplanocin A(CAS:102052-95-9)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 3-Deazaneplanocin A (DZNep) 是一种有效的组蛋白甲基转移酶 (histone methyltransferase,EZH2) 抑制剂
Introduction3eazaneplanocin A (DZNep) is a potenthistone methyltransferase EZH2inhibitor.
Application1
Application2
Application3
3-Deazaneplanocin A (DZNep) 是一种有效的组蛋白甲基转移酶 (histone methyltransferase,EZH2) 抑制剂。3-Deazaneplanocin A (DZNep) is a potenthistone methyltransferase EZH2inhibitor.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Fiskus W, et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood, 2009, 114(13), 2733-2743.
【2】.Avan A, et al. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. Mol Cancer Ther. 2012 Aug;11(8):1735-46.
【3】.Kikuchi J, et al. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer. 2012 Nov;78(2):138-43.
【4】.Sun F, et al. Preclinical pharmacokinetic studies of 3-deazaneplanocin A, a potent epigenetic anticancer agent, and its human pharmacokinetic prediction using GastroPlus. Eur J Pharm Sci. 2015 Sep 18;77:290-302.
【5】.Siddiqi FS, et al. The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes. J Am Soc Nephrol. 2016 Jul;27(7):2021-34.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents